BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 12, 2008
View Archived Issues
Pfizer develops new series of PDE5 inhibitors for once-daily dosing
Read More
TRO-40303 demonstrates cardioprotective effects after ischemia-reperfusion in vivo
Read More
Novel prodrugs for HCV may represent an improvement over valopicitabine
Read More
Bionomics presents data on novel vascular disruption agents for cancer
Read More
Recent patents disclose novel analgesic agents
Read More
TRITON-TIMI 38: Prasugrel reduces recurrent cardiovascular events
Read More
Allopurinol lowers blood pressure in adolescents with hypertension
Read More
Abraxis and ProMetic enter worldwide agreements for four biopharmaceuticals
Read More
Cytokinetics initiates dosing in phase IIa clinical trial of CK-1827452 in stable heart failure
Read More
Nanotherapeutics submits IND to FDA for phase IIa clinical study of NanoDOX
Read More
FDA schedules advisory committee meeting with Novo Nordisk for liraglutide NDA
Read More
Submicromolar Hsp90 inhibitors identified by TopoTarget
Read More
Medarex receives milestone payment from Pfizer following filing of IND with FDA
Read More
FDA approves TopoTarget's SPA for a phase III trial of belinostat in PTCL
Read More
AMRI and BMS select second compound for clinical development for CNS diseases
Read More
Pro-Pharmaceuticals submits data to FDA for pre-IND meeting on antihypoxia drug
Read More
Recent IRM and AstraZeneca patents report new agents for treating respiratory disorders
Read More
Novel treatments for diabetes and related disorders disclosed in recent patents
Read More
Pfizer to withdraw global marketing applications for dalbavancin in order to conduct phase III trial
Read More
Oramed signs agreement with ETI Karle Clinical to conduct a phase IIb clinical trial of ORMD-0801
Read More
Oxford BioMedica reports positive interim results from phase I/II trial of ProSavin in Parkinson's
Read More
RegeneRx reports results from phase Ia clinical trial of RGN-352 in healthy subjects
Read More
Epiphany presents a report on the clinical development of valomaciclovir in herpes zoster
Read More
FDA accepts inhaled treprostinil NDA for review
Read More
Schering-Plough launches Bridion in Europe
Read More
Data indicate CEL-2000 vaccine prevents or retards permanent damage of RA
Read More
PainCeptor presents clinical results for PPC-5650 in pain
Read More